BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11533152)

  • 1. Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants.
    Lauring AS; Anderson MM; Overbaugh J
    J Virol; 2001 Oct; 75(19):8888-98. PubMed ID: 11533152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and biochemical analyses of receptor and cofactor determinants for T-cell-tropic feline leukemia virus infection.
    Lauring AS; Cheng HH; Eiden MV; Overbaugh J
    J Virol; 2002 Aug; 76(16):8069-78. PubMed ID: 12134012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2.
    Sugai J; Eiden M; Anderson MM; Van Hoeven N; Meiering CD; Overbaugh J
    J Virol; 2001 Aug; 75(15):6841-9. PubMed ID: 11435563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses.
    Anderson MM; Lauring AS; Robertson S; Dirks C; Overbaugh J
    J Virol; 2001 Nov; 75(22):10563-72. PubMed ID: 11602698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Envelope determinants for dual-receptor specificity in feline leukemia virus subgroup A and T variants.
    Cheng HH; Anderson MM; Hankenson FC; Johnston L; Kotwaliwale CV; Overbaugh J
    J Virol; 2006 Feb; 80(4):1619-28. PubMed ID: 16439518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion-defective gibbon ape leukemia virus vectors can be rescued by homologous but not heterologous soluble envelope proteins.
    Farrell KB; Ting YT; Eiden MV
    J Virol; 2002 May; 76(9):4267-74. PubMed ID: 11932392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains.
    Gwynn SR; Hankenson FC; Lauring AS; Rohn JL; Overbaugh J
    J Virol; 2000 Jul; 74(13):5754-61. PubMed ID: 10846053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A soluble envelope protein of endogenous retrovirus (FeLIX) present in serum of domestic cats mediates infection of a pathogenic variant of feline leukemia virus.
    Sakaguchi S; Shojima T; Fukui D; Miyazawa T
    J Gen Virol; 2015 Mar; 96(Pt 3):681-687. PubMed ID: 25395593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.
    Boomer S; Eiden M; Burns CC; Overbaugh J
    J Virol; 1997 Nov; 71(11):8116-23. PubMed ID: 9343161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
    Tailor CS; Kabat D
    J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a cellular cofactor required for infection by feline leukemia virus.
    Anderson MM; Lauring AS; Burns CC; Overbaugh J
    Science; 2000 Mar; 287(5459):1828-30. PubMed ID: 10710311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FeLIX is a restriction factor for mammalian retrovirus infection.
    Pramono D; Takeuchi D; Katsuki M; AbuEed L; Abdillah D; Kimura T; Kawasaki J; Miyake A; Nishigaki K
    J Virol; 2024 Apr; 98(4):e0177123. PubMed ID: 38440982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host cell range of T-lymphotropic feline leukemia virus in vitro.
    Shojima T; Nakata R; Miyazawa T
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1466-70. PubMed ID: 16730653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feline leukemia virus T entry is dependent on both expression levels and specific interactions between cofactor and receptor.
    Cheng HH; Anderson MM; Overbaugh J
    Virology; 2007 Mar; 359(1):170-8. PubMed ID: 17046042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
    Chandhasin C; Coan PN; Levy LS
    J Virol; 2005 Feb; 79(3):1351-60. PubMed ID: 15650161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors.
    Moser M; Burns CC; Boomer S; Overbaugh J
    Virology; 1998 Mar; 242(2):366-77. PubMed ID: 9514965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline leukemia virus infection requires a post-receptor binding envelope-dependent cellular component.
    Hussain N; Thickett KR; Na H; Leung C; Tailor CS
    J Virol; 2011 Dec; 85(23):12529-36. PubMed ID: 21917946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant.
    Miyake A; Kawasaki J; Ngo H; Makundi I; Muto Y; Khan AH; Smith DJ; Nishigaki K
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and species resistance to murine amphotropic, gibbon ape, and feline subgroup C leukemia viruses is strongly influenced by receptor expression levels and by receptor masking mechanisms.
    Tailor CS; Nouri A; Kabat D
    J Virol; 2000 Oct; 74(20):9797-801. PubMed ID: 11000257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive approach to mapping the interacting surfaces of murine amphotropic and feline subgroup B leukemia viruses with their cell surface receptors.
    Tailor CS; Nouri A; Kabat D
    J Virol; 2000 Jan; 74(1):237-44. PubMed ID: 10590111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.